COMMUNIQUÉS West-GlobeNewswire

TerrAscend Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:10

Net Revenue of $74.2 million and Gross Profit Margin of 48.8% 9 th consecutive quarter of positive Cash Flow from continuing operations and fifth consecutive quarter of positive Free Cash Flow 1 Closed on a senior [...]

Pennant Reports Third Quarter 2024 Results

06/11/2024 - 22:11

Conference Call and Webcast scheduled for tomorrow, November 7, 2024 at 10:00 am MT EAGLE, Idaho, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of [...]

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

06/11/2024 - 22:12

Reports Q3 2024 Total Revenues of $ 128.7 Million, Representing a 25.3 % YoY Increase Record Revenues Driven by Continued Organic Growth in its Rare Disease Franchise Robust Financial Performance Highlights Operational [...]

Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:15

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first patient dosed for a Phase 2 trial in recurrent C. difficile infection, and IND clearance for a [...]

Certara Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:15

Updates Full Year 2024 Financial Guidance RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the [...]

Virbac : Déclaration d'actions et de droits de vote 10/2024

06/11/2024 - 16:04

DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights 10/2024

06/11/2024 - 16:04

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024

06/11/2024 - 16:47

AGOURA HILLS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at SITC 2024. Dr. Cynthia Lee, VP of R&D will be presenting Sapu Bio pipeline of [...]

Genmab Announces Financial Results for the First Nine Months of 2024

06/11/2024 - 17:02

November 6, 2024 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2024 Highlights European Commission (EC) granted conditional marketing authorization for TEPKINLY ® (epcoritamab) as a [...]

Update of financial guidance for 2024

06/11/2024 - 17:46

GN has throughout the year increased its earnings power and cash flow generation, leading to an upgrade of the guidance on free cash flow excl. M&A to “DKK >1,100 million” and a confirmation of the EBITA margin [...]

Interim Report Q3 2024: Further margin expansion and strong cash flow despite mixed growth across divisions

06/11/2024 - 17:54

Highlights The Hearing division continued to gain significant market share leading to 10% organic revenue growth, while the divisional profit margin increased by 5.9 percentage points to 34.8% The Enterprise division [...]

SYNDEO Medical Announces European MDR Approval for Two Product Brands

06/11/2024 - 17:59

ZAVENTEM, Belgium, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgium-based leader in diagnostic and interventional procedural solutions, announces that its two flagship product brands, SYNDEOPack [...]

SAFE - Sortie de redressement judiciaire pour Safe

06/11/2024 - 18:00

Sortie de redressement judiciaire pour Safe Fleurieux-sur-l’Arbresle - France - le 6 novembre 2024 à 18h . Safe SA et ses filiales annoncent être sorties de la procédure de redressement judiciaire par jugement du [...]

Zenith Labs: Embracing a Holistic Approach to Anti-Aging

06/11/2024 - 18:00

MCHENRY, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- The increasing demand for dietary supplements is indicative of a larger cultural shift toward holistic health practices. Analysts project that the market will grow from [...]

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

06/11/2024 - 14:00

– Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – Strong balance sheet [...]

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

06/11/2024 - 14:00

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief Financial Officer, and Greg Cosgrove, M.D. FCCP, will participate in a [...]

EDAP to Participate in the 2024 Jefferies London Healthcare Conference

06/11/2024 - 14:00

LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor [...]

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

06/11/2024 - 14:00

State-of-the-Art Pharmacy Completes LifeMD’s End-to-end Healthcare Platform, Supporting 5,000 Daily Orders, Improving Operating Margins, and Enabling Curated Care Journeys NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- [...]

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

06/11/2024 - 14:00

DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]